{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T08:50:26Z","timestamp":1782118226871,"version":"3.54.5"},"update-to":[{"DOI":"10.1002\/14651858.cd015698","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:00:00Z","timestamp":1759968000000}}],"reference-count":148,"publisher":"Wiley","issue":"10","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd015698.pub2","type":"journal-article","created":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T11:29:54Z","timestamp":1760009394000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Intraperitoneal chemotherapy for gastric cancer"],"prefix":"10.1002","volume":"2025","author":[{"given":"Mingchun","family":"Mu","sequence":"additional","affiliation":[{"name":"Department of General Surgery; West China Hospital, Sichuan University; Chengdu China"},{"name":"Gastric Cancer Center; West China Hospital, Sichuan University; Chengdu China"},{"name":"Laboratory of Gastric Cancer, State Key Laboratory of Biotherapy and Cancer Center; West China Hospital, Sichuan University; Chengdu China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaolun","family":"Cai","sequence":"additional","affiliation":[{"name":"Department of General Surgery; West China Hospital, Sichuan University; Chengdu China"},{"name":"Gastric Cancer Center; West China Hospital, Sichuan University; Chengdu China"},{"name":"Laboratory of Gastric Cancer, State Key Laboratory of Biotherapy and Cancer Center; West China Hospital, Sichuan University; Chengdu China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajun","family":"Hu","sequence":"additional","affiliation":[{"name":"West China Clinical Medical College; Sichuan University; Chengdu China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueting","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Medical Discipline Construction; West China Hospital, Sichuan University; Chengdu China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of General Surgery; West China Hospital, Sichuan University; Chengdu China"},{"name":"Gastric Cancer Center; West China Hospital, Sichuan University; Chengdu China"},{"name":"Laboratory of Gastric Cancer, State Key Laboratory of Biotherapy and Cancer Center; West China Hospital, Sichuan University; Chengdu China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixin","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of General Surgery; West China Hospital, Sichuan University; Chengdu China"},{"name":"Gastric Cancer Center; West China Hospital, Sichuan University; Chengdu China"},{"name":"Laboratory of Gastric Cancer, State Key Laboratory of Biotherapy and Cancer Center; West China Hospital, Sichuan University; Chengdu China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiankun","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of General Surgery; West China Hospital, Sichuan University; Chengdu China"},{"name":"Gastric Cancer Center; West China Hospital, Sichuan University; Chengdu China"},{"name":"Laboratory of Gastric Cancer, State Key Laboratory of Biotherapy and Cancer Center; West China Hospital, Sichuan University; Chengdu China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8891-5736","authenticated-orcid":false,"given":"Kun","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of General Surgery; West China Hospital, Sichuan University; Chengdu China"},{"name":"Gastric Cancer Center; West China Hospital, Sichuan University; Chengdu China"},{"name":"Laboratory of Gastric Cancer, State Key Laboratory of Biotherapy and Cancer Center; West China Hospital, Sichuan University; Chengdu China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,10,9]]},"reference":[{"issue":"3","key":"10.1002\/14651858.CD015698.pub2-BIB0001|cit1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA: a Cancer Journal for Clinicians"},{"key":"10.1002\/14651858.CD015698.pub2-BIB0002|cit2","unstructured":"National Cancer Institute Stomach cancer \u2013 cancer stat facts. Surveillance, Epidemiology, and End Results (SEER) Program https:\/\/seer.cancer.gov\/statfacts\/html\/stomach.html"},{"issue":"8","key":"10.1002\/14651858.CD015698.pub2-BIB0003|cit3","doi-asserted-by":"publisher","first-page":"3662","DOI":"10.1002\/cam4.1661","article-title":"Frequency and clinicopathological features of metastasis to liver, lung, bone, and brain from gastric cancer: a SEER-based study","volume":"7","author":"Qiu","year":"2018","journal-title":"Cancer Medicine"},{"issue":"3","key":"10.1002\/14651858.CD015698.pub2-BIB0004|cit4","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1002\/ijc.28373","article-title":"Peritoneal carcinomatosis of gastric origin: a population-based study on incidence, survival and risk factors","volume":"134","author":"Thomassen","year":"2014","journal-title":"International Journal of Cancer"},{"issue":"2","key":"10.1002\/14651858.CD015698.pub2-BIB0005|cit5","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD015014.pub2","article-title":"Uncut Roux-en-Y reconstruction after distal gastrectomy for gastric cancer","author":"Cai","year":"2024","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD015698.pub2-BIB0006|cit6","unstructured":"National Comprehensive Cancer Network (NCCN) NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines\u00ae) for Gastric Cancer; Version 2; 2025 Available at https:\/\/www.nccn.org"},{"issue":"4","key":"10.1002\/14651858.CD015698.pub2-BIB0007|cit7","doi-asserted-by":"publisher","first-page":"203","DOI":"10.2165\/11598890-000000000-00000","article-title":"Pharmacokinetics and pharmacodynamics of intraperitoneal cancer chemotherapeutics","volume":"51","author":"Hasovits","year":"2012","journal-title":"Clinical Pharmacokinetics"},{"issue":"4","key":"10.1002\/14651858.CD015698.pub2-BIB0008|cit8","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1007\/s10120-021-01160-1","article-title":"Synchronous peritoneal metastases of gastric cancer origin: incidence, treatment and survival of a nationwide Dutch cohort","volume":"24","author":"Koemans","year":"2021","journal-title":"Gastric Cancer"},{"issue":"3","key":"10.1002\/14651858.CD015698.pub2-BIB0009|cit9","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/S1470-2045(15)00553-7","article-title":"Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3, randomised controlled trial","volume":"17","author":"Fujitani","year":"2016","journal-title":"Lancet Oncology"},{"issue":"12","key":"10.1002\/14651858.CD015698.pub2-BIB0010|cit10","doi-asserted-by":"publisher","first-page":"3173","DOI":"10.1245\/s10434-010-1183-0","article-title":"Positive peritoneal cytology in patients with gastric cancer: natural history and outcome of 291 patients","volume":"17","author":"Mezhir","year":"2010","journal-title":"Annals of Surgical Oncology"},{"issue":"18","key":"10.1002\/14651858.CD015698.pub2-BIB0011|cit11","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1001\/jama.1955.02960350004002","article-title":"Use of nitrogen mustard in treatment of serous effusions of neoplastic origin","volume":"159","author":"Weisberger","year":"1955","journal-title":"Journal of the American Medical Association"},{"issue":"2","key":"10.1002\/14651858.CD015698.pub2-BIB0012|cit12","first-page":"253","article-title":"Hyperthermic peritoneal perfusion system in canines","volume":"40","author":"Spratt","year":"1980","journal-title":"Cancer Research"},{"issue":"2","key":"10.1002\/14651858.CD015698.pub2-BIB0013|cit13","first-page":"256","article-title":"Clinical delivery system for intraperitoneal hyperthermic chemotherapy","volume":"40","author":"Spratt","year":"1980","journal-title":"Cancer Research"},{"key":"10.1002\/14651858.CD015698.pub2-BIB0014|cit14","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.addr.2020.01.003","article-title":"Molecular and biological rationale of hyperthermia as radio- and chemosensitizer","volume":"163-4","author":"Oei","year":"2020","journal-title":"Advanced Drug Delivery Reviews"},{"issue":"7","key":"10.1002\/14651858.CD015698.pub2-BIB0015|cit15","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1007\/s00464-012-2148-0","article-title":"Description of a novel approach for intraperitoneal drug delivery and the related device","volume":"26","author":"Solass","year":"2012","journal-title":"Surgical Endoscopy"},{"issue":"2","key":"10.1002\/14651858.CD015698.pub2-BIB0016|cit16","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1245\/s10434-013-3213-1","article-title":"Intraperitoneal chemotherapy of peritoneal carcinomatosis using pressurized aerosol as an alternative to liquid solution: first evidence for efficacy","volume":"21","author":"Solass","year":"2014","journal-title":"Annals of Surgical Oncology"},{"issue":"1","key":"10.1002\/14651858.CD015698.pub2-BIB0017|cit17","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3390\/cancers12010034","article-title":"Overcoming drug resistance by taking advantage of physical principles: pressurized intraperitoneal aerosol chemotherapy (PIPAC)","volume":"12","author":"Nadiradze","year":"2019","journal-title":"Cancers"},{"key":"10.1002\/14651858.CD015698.pub2-BIB0018|cit18","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s44178-022-00004-x","article-title":"CACA guidelines for holistic integrative management of gastric cancer","volume":"1","author":"Society of Gastric Cancer of China Anti-Cancer Association","year":"2022","journal-title":"Holistic Integrative Oncology"},{"issue":"3","key":"10.1002\/14651858.CD015698.pub2-BIB0019|cit19","doi-asserted-by":"publisher","first-page":"570","DOI":"10.3390\/cancers14030570","article-title":"Review of regional therapies for gastric cancer with peritoneal metastases","volume":"14","author":"Sun","year":"2022","journal-title":"Cancers"},{"issue":"7","key":"10.1002\/14651858.CD015698.pub2-BIB0020|cit20","doi-asserted-by":"publisher","first-page":"756","DOI":"10.4251\/wjgo.v12.i7.756","article-title":"Comparison of open and closed hyperthermic intraperitoneal chemotherapy: results from the United States hyperthermic intraperitoneal chemotherapy collaborative","volume":"12","author":"Leiting","year":"2020","journal-title":"World Journal of Gastrointestinal Oncology"},{"issue":"4","key":"10.1002\/14651858.CD015698.pub2-BIB0021|cit21","doi-asserted-by":"publisher","first-page":"824","DOI":"10.3109\/0284186X.2012.702925","article-title":"Phase II study of patients with peritoneal carcinomatosis from gastric cancer treated with preoperative systemic chemotherapy followed by peritonectomy and intraperitoneal chemotherapy","volume":"52","author":"Hultman","year":"2013","journal-title":"Acta Oncologica"},{"issue":"3","key":"10.1002\/14651858.CD015698.pub2-BIB0022|cit22","doi-asserted-by":"publisher","first-page":"270","DOI":"10.4143\/crt.2014.46.3.270","article-title":"Early postoperative intraperitoneal chemotherapy for macroscopically serosa-invading gastric cancer patients","volume":"46","author":"Kwon","year":"2014","journal-title":"Cancer Research and Treatment"},{"key":"10.1002\/14651858.CD015698.pub2-BIB0023|cit23","doi-asserted-by":"publisher","first-page":"905922","DOI":"10.3389\/fonc.2022.905922","article-title":"Efficacy and safety of conversion therapy by intraperitoneal and intravenous paclitaxel plus oral S-1 in gastric cancer patients with peritoneal metastasis: a prospective phase II study","volume":"12","author":"Yang","year":"2022","journal-title":"Frontiers in Oncology"},{"key":"10.1002\/14651858.CD015698.pub2-BIB0024|cit24","doi-asserted-by":"publisher","first-page":"153303382110363","DOI":"10.1177\/15330338211036310","article-title":"Neoadjuvant intraperitoneal and systemic chemotherapy versus neoadjuvant systemic chemotherapy with docetaxel, oxaliplatin, and S-1 for gastric cancer with peritoneal metastasis: a propensity score matched analysis","volume":"20","author":"Zhang","year":"2021","journal-title":"Technology in Cancer Research & Treatment"},{"key":"10.1002\/14651858.CD015698.pub2-BIB0025|cit25","doi-asserted-by":"publisher","first-page":"864647","DOI":"10.3389\/fonc.2022.864647","article-title":"Gastric cancer with peritoneal metastasis - a comprehensive review of current intraperitoneal treatment modalities","volume":"12","author":"Prabhu","year":"2022","journal-title":"Frontiers in Oncology"},{"issue":"10","key":"10.1002\/14651858.CD015698.pub2-BIB0026|cit26","doi-asserted-by":"publisher","first-page":"5975","DOI":"10.21873\/anticanres.12945","article-title":"Intraperitoneal and systemic chemotherapy for patients with gastric cancer with peritoneal metastasis: a phase II trial","volume":"38","author":"Shinkai","year":"2018","journal-title":"Anticancer Research"},{"issue":"12","key":"10.1002\/14651858.CD015698.pub2-BIB0027|cit27","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1016\/j.ejso.2019.07.030","article-title":"Hyperthermic intraperitoneal chemotherapy in serosa-invasive gastric cancer patients","volume":"45","author":"Reutovich","year":"2019","journal-title":"European Journal of Surgical Oncology"},{"issue":"6","key":"10.1002\/14651858.CD015698.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1245\/s10434-011-1631-5","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer: final results of a phase III randomized clinical trial","volume":"18","author":"Yang","year":"2011","journal-title":"Annals of Surgical Oncology"},{"issue":"1","key":"10.1002\/14651858.CD015698.pub2-BIB0029|cit29","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.ejso.2020.05.021","article-title":"Pressurized intraperitoneal aerosol chemotherapy (PIPAC) for unresectable peritoneal metastasis from gastric cancer","volume":"47","author":"Alyami","year":"2021","journal-title":"European Journal of Surgical Oncology"},{"issue":"5","key":"10.1002\/14651858.CD015698.pub2-BIB0030|cit30","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1002\/jso.25823","article-title":"Does hipec improve outcomes in gastric cancer patients treated with perioperative chemotherapy and radical surgery? A propensity-score matched analysis","volume":"121","author":"Diniz","year":"2020","journal-title":"Journal of Surgical Oncology"},{"issue":"19","key":"10.1002\/14651858.CD015698.pub2-BIB0031|cit31","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1200\/JCO.2018.77.8613","article-title":"Phase III trial comparing intraperitoneal and intravenous paclitaxel plus S-1 versus cisplatin plus S-1 in patients with gastric cancer with peritoneal metastasis: PHOENIX-GC Trial","volume":"36","author":"Ishigami","year":"2018","journal-title":"Journal of Clinical Oncology"},{"issue":"6","key":"10.1002\/14651858.CD015698.pub2-BIB0032|cit32","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1007\/s10120-018-0817-y","article-title":"A randomized phase II multicenter trial to explore efficacy of weekly intraperitoneal in comparison with intravenous paclitaxel administered immediately after gastrectomy to the patients with high risk of peritoneal recurrence: final results of the INPACT trial","volume":"21","author":"Takahashi","year":"2018","journal-title":"Gastric Cancer"},{"issue":"6","key":"10.1002\/14651858.CD015698.pub2-BIB0033|cit33","doi-asserted-by":"publisher","first-page":"2877","DOI":"10.1002\/cam4.2204","article-title":"Hyperthermic intraperitoneal chemotherapy (HIPEC) in combined treatment of locally advanced and intraperitonealy disseminated gastric cancer: a retrospective cooperative Central-Eastern European study","volume":"8","author":"Yarema","year":"2019","journal-title":"Cancer Medicine"},{"issue":"2","key":"10.1002\/14651858.CD015698.pub2-BIB0034|cit34","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3760\/cma.j.issn.0376-2491.2020.02.003","article-title":"Chinese expert consensus on clinical application of hyperthermic intraperitoneal chemotherapy (2019 edition)","volume":"100","author":"Society of Peritoneal Cancer of China Anti-Cancer A","year":"2020","journal-title":"National Medical Journal of China"},{"issue":"11","key":"10.1002\/14651858.CD015698.pub2-BIB0035|cit35","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.1002\/cncr.32868","article-title":"The Chicago Consensus on peritoneal surface malignancies: management of gastric metastases","volume":"126","author":"Chicago Consensus Working Group","year":"2020","journal-title":"Cancer"},{"key":"10.1002\/14651858.CD015698.pub2-BIB0036|cit36","volume-title":"CACA Guidelines for Holistic Integrative Management of Cancer","author":"Fan","year":"2022"},{"issue":"10","key":"10.1002\/14651858.CD015698.pub2-BIB0037|cit37","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/j.annonc.2022.07.004","article-title":"Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"33","author":"Lordick","year":"2022","journal-title":"Annals of Oncology"},{"issue":"2","key":"10.1002\/14651858.CD015698.pub2-BIB0038|cit38","doi-asserted-by":"publisher","first-page":"109499","DOI":"10.1016\/j.ejso.2024.109499","article-title":"Outcomes of intraperitoneal chemotherapy for the treatment of gastric cancer with peritoneal metastasis: a comprehensive systematic review and meta-analysis","volume":"51","author":"Boshier","year":"2025","journal-title":"European Journal of Surgical Oncology"},{"issue":"1","key":"10.1002\/14651858.CD015698.pub2-BIB0039|cit39","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1245\/s10434-024-16298-2","article-title":"Exploring the efficacy of hyperthermic intraperitoneal perfusion chemotherapy in gastric cancer: meta-analysis based on randomized controlled trials","volume":"32","author":"Chen","year":"2025","journal-title":"Annals of Surgical Oncology"},{"issue":"51","key":"10.1002\/14651858.CD015698.pub2-BIB0040|cit40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/KWDG6338","article-title":"Hyperthermic intraoperative peritoneal chemotherapy and cytoreductive surgery for people with peritoneal metastases: a systematic review and cost-effectiveness analysis","volume":"28","author":"Gurusamy","year":"2024","journal-title":"Health Technology Assessment"},{"key":"10.1002\/14651858.CD015698.pub2-BIB0041|cit41","unstructured":"Pei L Meta-analysis of efficacy and safety of hyperthermic intraperitonealchemotherapy combined with intravenous chemotherapy in thetreatment of gastric cancer with peritoneal metastasis (Thesis) Jilin University (2024)"},{"issue":"11","key":"10.1002\/14651858.CD015698.pub2-BIB0042|cit42","doi-asserted-by":"publisher","first-page":"3320","DOI":"10.3390\/jcm13113320","article-title":"Pressurized intraperitoneal aerosol chemotherapy (PIPAC) in the treatment of gastric cancer: feasibility, efficacy and safety- a systematic review and meta-analysis","volume":"13","author":"Ramalho-Vasconcelos","year":"2024","journal-title":"Journal of Clinical Medicine"},{"key":"10.1002\/14651858.CD015698.pub2-BIB0043|cit43","doi-asserted-by":"publisher","first-page":"1466473","DOI":"10.3389\/fonc.2024.1466473","article-title":"Optimal hyperthermic intraperitoneal chemotherapy regimen for advanced and peritoneal metastatic gastric cancer: a systematic review and Bayesian network meta-analysis","volume":"14","author":"Wang","year":"2024","journal-title":"Frontiers in oncology"},{"issue":"CD015698","key":"10.1002\/14651858.CD015698.pub2-BIB0044|cit44","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD015698","article-title":"Intraperitoneal chemotherapy for primary gastric cancer","author":"Mu","year":"2023","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD015698.pub2-BIB0045|cit45","unstructured":"Higgins JP Lasserson T Thomas J Flemyng E Churchill R Methodological expectations of Cochrane intervention reviews. Cochrane: London, Version August 2023 Available from https:\/\/community.cochrane.org\/mecir-manual"},{"key":"10.1002\/14651858.CD015698.pub2-BIB0046|cit46","doi-asserted-by":"publisher","first-page":"n160","DOI":"10.1136\/bmj.n160","article-title":"PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD015698.pub2-BIB0047|cit47","volume-title":"AJCC Cancer Staging Manual","author":"Amin","year":"2017"},{"issue":"6","key":"10.1002\/14651858.CD015698.pub2-BIB0048|cit48","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1007\/s004230050246","article-title":"Management of peritoneal-surface malignancy: the surgeon's role","volume":"384","author":"Sugarbaker","year":"1999","journal-title":"Langenbeck's Archives of Surgery \/ Deutsche Gesellschaft fur Chirurgie"},{"key":"10.1002\/14651858.CD015698.pub2-BIB0049|cit49","unstructured":"Safety reporting requirements for INDs and BA\/BE studies https:\/\/www.fda.gov\/media\/79394\/download"},{"key":"10.1002\/14651858.CD015698.pub2-BIB0050|cit50","unstructured":"International Council for Harmonisation (ICH) Integrated addendum to ICHE6 (R1): guideline for good clinical practice E6 (R2); 2016 https:\/\/database.ich.org\/sites\/default\/files\/E6_R2_Addendum.pdf"},{"issue":"2","key":"10.1002\/14651858.CD015698.pub2-BIB0051|cit51","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","article-title":"Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey","volume":"240","author":"Dindo","year":"2004","journal-title":"Annals of Surgery"},{"key":"10.1002\/14651858.CD015698.pub2-BIB0052|cit52","unstructured":"National Cancer Institute Common Terminology Criteria for Adverse Events (CTCAE) https:\/\/ctep.cancer.gov\/protocoldevelopment\/electronic_applications\/ctc.htm"},{"key":"10.1002\/14651858.CD015698.pub2-BIB0053|cit53","unstructured":"National Cancer Institute (NCI) Dictionary https:\/\/www.cancer.gov\/publications\/dictionaries\/cancer-terms\/def\/rfs"},{"issue":"6","key":"10.1002\/14651858.CD015698.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection","volume":"30","author":"Sherbourne","year":"1992","journal-title":"Medical Care"},{"issue":"5","key":"10.1002\/14651858.CD015698.pub2-BIB0055|cit55","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","article-title":"The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology","volume":"85","author":"Aaronson","year":"1993","journal-title":"Journal of the National Cancer Institute"},{"issue":"2","key":"10.1002\/14651858.CD015698.pub2-BIB0056|cit56","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1023\/a:1026429831234","article-title":"Modification of the EORTC QLQ-C30 (version 2.0) based on content validity and reliability testing in large samples of patients with cancer","volume":"6","author":"Osoba","year":"1997","journal-title":"Quality of Life Research"},{"key":"10.1002\/14651858.CD015698.pub2-BIB0057|cit57","unstructured":"Publish or Perish Harzing A-W 2021"},{"key":"10.1002\/14651858.CD015698.pub2-BIB0058|cit58","unstructured":"Lefebvre C Glanville J Briscoe S Featherstone R Littlewood A Technical Supplement to Chapter 4: Searching for and selecting studies (chapter last updated September 2024). In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 6.5. Cochrane, 2024 Available from https:\/\/cochrane.org\/handbook"},{"issue":"1","key":"10.1002\/14651858.CD015698.pub2-BIB0059|cit59","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1186\/s13643-017-0644-y","article-title":"Optimal database combinations for literature searches in systematic reviews: a prospective exploratory study","volume":"6","author":"Bramer","year":"2017","journal-title":"Systematic Reviews"},{"key":"10.1002\/14651858.CD015698.pub2-BIB0060|cit60","unstructured":"EndNote Clarivate Analytics 2013"},{"key":"10.1002\/14651858.CD015698.pub2-BIB0061|cit61","unstructured":"Covidence Veritas Health Innovation 2025"},{"issue":"1","key":"10.1002\/14651858.CD015698.pub2-BIB0062|cit62","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s41073-023-00130-8","article-title":"Checklist to assess Trustworthiness in RAndomised Controlled Trials (TRACT checklist): concept proposal and pilot","volume":"8","author":"Mol","year":"2023","journal-title":"Research Integrity and Peer Review"},{"issue":"3","key":"10.1002\/14651858.CD015698.pub2-BIB0063|cit63","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1002\/jrsm.1599","article-title":"Identifying and managing problematic trials: A research integrity assessment tool for randomized controlled trials in evidence synthesis","volume":"14","author":"Weibel","year":"2023","journal-title":"Research Synthesis Methods"},{"key":"10.1002\/14651858.CD015698.pub2-BIB0064|cit64","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/1745-6215-10-46","article-title":"Randomized trials published in some Chinese journals: how many are randomized?","volume":"10","author":"Wu","year":"2009","journal-title":"Trials"},{"key":"10.1002\/14651858.CD015698.pub2-BIB0065|cit65","unstructured":"Engauge Digitizer Software Mitchell M Muftakhidinov B Winchen T Wilms A van Schaik B Mitchell M 2019"},{"key":"10.1002\/14651858.CD015698.pub2-BIB0066|cit66","unstructured":"Review Manager (RevMan) The Cochrane Collaboration 2024"},{"key":"10.1002\/14651858.CD015698.pub2-BIB0067|cit67","unstructured":"Higgins JP Savovi\u0107 J Page MJ Elbers RG Sterne JA Chapter 8: Assessing risk of bias in a randomized trial [(chapter last updated October 2019). In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 6.5. Cochrane, 2024 Available from https:\/\/cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD015698.pub2-BIB0068|cit68","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD015698.pub2-BIB0069|cit69","unstructured":"Higgins JP Li T Deeks JJ Chapter 6: Choosing effect measures and computing estimates of effect (chapter last updated August 2023). In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 6.5. Cochrane, 2024 Available from https:\/\/cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD015698.pub2-BIB0070|cit70","unstructured":"Higgins JP Eldridge S Li T Chapter 23: Including variants on randomized trials (chapter last updated October 2019). In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 6.5. Cochrane, 2024 Available from https:\/\/cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD015698.pub2-BIB0071|cit71","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1745-6215-8-16","article-title":"Practical methods for incorporating summary time-to-event data into meta-analysis","volume":"8","author":"Tierney","year":"2007","journal-title":"Trials"},{"key":"10.1002\/14651858.CD015698.pub2-BIB0072|cit72","unstructured":"Page MJ Higgins JP Sterne JA Chapter 13: Assessing risk of bias due to missing evidence in a meta-analysis [(chapter last updated August 2024). In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA , editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 6.5. Cochrane, 2024 Available from https:\/\/cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD015698.pub2-BIB0073|cit73","unstructured":"Deeks JJ Higgins JP Altman DG McKenzie JE Veroniki AA Chapter 10: Analysing data and undertaking meta-analyses (chapter last updated November 2024). In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 6.5. Cochrane, 2024 Available from https:\/\/cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD015698.pub2-BIB0074|cit74","unstructured":"McKenzie JE Brennan SE Chapter 12: Synthesizing and presenting findings using other methods (chapter last updated October 2019). In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 6.5. Cochrane, 2024 Available from https:\/\/cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD015698.pub2-BIB0075|cit75","unstructured":"Sch\u00fcnemann HJ Higgins JP Vist GE Glasziou P Akl EA Skoetz N Chapter 14: Completing \u2018Summary of findings\u2019 tables and grading the certainty of the evidence (chapter last updated August 2023). In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 6.5. Cochrane, 2024 Available from https:\/\/cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD015698.pub2-BIB0076|cit76","unstructured":"Sch\u00fcnemann HJ Vist GE Higgins JP Santesso N Deeks JJ Glasziou P Chapter 15: Interpreting results and drawing conclusions (chapter last updated August 2023). In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 6.5. Cochrane, 2024 Available from https:\/\/cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD015698.pub2-BIB0077|cit77","unstructured":"GRADEpro GDT McMaster University (developed by Evidence Prime) 2025"},{"key":"10.1002\/14651858.CD015698.pub2-BIB0078|cit78","doi-asserted-by":"publisher","first-page":"e12093","DOI":"10.1002\/cesm.12093","article-title":"How to present an informative summary of findings table for systematic reviews of interventions: a tutorial","volume":"6","author":"Hilgart","journal-title":"Cochrane Evidence Synthesis and Methods"},{"key":"10.1002\/14651858.CD015698.pub2-BIB0079|cit79","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.jclinepi.2019.10.015","article-title":"GRADE guidelines 27: how to calculate absolute effects for time-to-event outcomes in summary of findings tables and Evidence Profiles","volume":"118","author":"Skoetz","year":"2020","journal-title":"Journal of Clinical Epidemiology"},{"issue":"1","key":"10.1002\/14651858.CD015698.pub2-BIB0080|cit80","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s13045-025-01698-y","article-title":"The current landscape of gastric cancer and gastroesophageal junction cancer diagnosis and treatment in China: a comprehensive nationwide cohort analysis","volume":"18","author":"Chen","year":"2025","journal-title":"Journal of Hematology & Oncology"},{"issue":"13","key":"10.1002\/14651858.CD015698.pub2-BIB0081|cit81","doi-asserted-by":"publisher","first-page":"11491","DOI":"10.1007\/s00432-023-05019-z","article-title":"Hyperthermic intraperitoneal chemotherapy (HIPEC) plus systemic chemotherapy versus systemic chemotherapy alone in locally advanced gastric cancer after D2 radical resection: a randomized-controlled study","volume":"149","author":"Yu","year":"2023","journal-title":"Journal of Cancer Research and Clinical Oncology"},{"key":"10.1002\/14651858.CD015698.pub2-BIB0082|cit82","unstructured":"A prospective randomized controlled trial of D2 radical resection combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of advanced gastric cancer https:\/\/www.chictr.org.cn\/showproj.html?proj=143073 (first received 30 January 2022)"},{"issue":"2","key":"10.1002\/14651858.CD015698.pub2-BIB0083|cit83","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1200\/JCO.22.02867","article-title":"Effect of hyperthermic intraperitoneal chemotherapy on cytoreductive surgery in gastric cancer with synchronous peritoneal metastases: the phase III GASTRIPEC-I trial","volume":"42","author":"Rau","year":"2024","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD015698.pub2-BIB0084|cit84","unstructured":"Cytoreductive surgery (CRS) with\/\u200bwithout HIPEC in gastric cancer with peritoneal carcinomatosis (GASTRIPEC) https:\/\/clinicaltrials.gov\/study\/NCT02158988"},{"issue":"Suppl 5","key":"10.1002\/14651858.CD015698.pub2-BIB0085|cit85","doi-asserted-by":"publisher","first-page":"S1040","DOI":"10.1016\/j.annonc.2021.08.1485","article-title":"1376O The effect of hyperthermic intraperitoneal chemotherapy (HIPEC) upon cytoreductive surgery (CRS) in gastric cancer (GC) with synchronous peritoneal metastasis (PM): a randomized multicentre phase III trial (GASTRIPEC-I-trial)","volume":"32","author":"Rau","year":"2021","journal-title":"Annals of Oncology"},{"key":"10.1002\/14651858.CD015698.pub2-BIB0086|cit86","unstructured":"Prospective multicenter phase III clinical trial using cytoreductive surgery with hyperthermic intraoperative chemotherapy (HIPEC) after preoperative chemotherapy in patients with peritoneal carcinomatosis of gastric cancer incl. adenocarcinoma of the esophagogastreal junction https:\/\/www.clinicaltrialsregister.eu\/ctr-search\/trial\/2006-006088-22\/DE"},{"issue":"15 Suppl","key":"10.1002\/14651858.CD015698.pub2-BIB0087|cit87","doi-asserted-by":"publisher","first-page":"TPS4132","DOI":"10.1200\/jco.2015.33.15_suppl.tps4132","article-title":"Perioperative chemotherapy and cytoreductive surgery with versus without HIPEC in gastric cancer with limited peritoneal metastases: a randomized phase III study (GASTRIPEC)","volume":"33","author":"Rau","year":"2015","journal-title":"Journal of Clinical Oncology"},{"issue":"5","key":"10.1002\/14651858.CD015698.pub2-BIB0088|cit88","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.3892\/etm.2014.1599","article-title":"Effect of neoadjuvant chemotherapy combined with hyperthermic intraperitoneal perfusion chemotherapy on advanced gastric cancer","volume":"7","author":"Cui","year":"2014","journal-title":"Experimental and Therapeutic Medicine"},{"key":"10.1002\/14651858.CD015698.pub2-BIB0089|cit89","unstructured":"Bai X Lu Z Li W Han G Zhang W Cui H [Early Cyclic Intraperitoneal Hyperthermic Perfusion after AGC Surgery] Proceedings of the 7th Chinese Academic Conference of Minimally Invasive Therapy in Oncology 2011 786 9"},{"issue":"23","key":"10.1002\/14651858.CD015698.pub2-BIB0090|cit90","doi-asserted-by":"publisher","first-page":"2740","DOI":"10.3969\/j.issn.1007-9572.2013.23.023","article-title":"Early Cyclic Intraperitoneal Hyperthermic Perfusion of Oxaliplatin Combined with Intravenous Chemotherapy after AGC Surgery","volume":"16","author":"Cui","year":"2013","journal-title":"Chinese General Practice"},{"issue":"1","key":"10.1002\/14651858.CD015698.pub2-BIB0091|cit91","doi-asserted-by":"publisher","first-page":"66","DOI":"10.21147\/j.issn.1000-9604.2025.01.05","article-title":"Prophylactic hyperthermic intraperitoneal chemotherapy in patients with locally advanced gastric cancer after curative surgery: Final results of a phase II trial","volume":"37","author":"Fan","year":"2025","journal-title":"Chinese Journal of Cancer Research"},{"issue":"1","key":"10.1002\/14651858.CD015698.pub2-BIB0092|cit92","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1186\/s12885-021-07925-2","article-title":"Phase II trial of prophylactic hyperthermic intraperitoneal chemotherapy in patients with locally advanced gastric cancer after curative surgery","volume":"21","author":"Fan","year":"2021","journal-title":"BMC Cancer"},{"key":"10.1002\/14651858.CD015698.pub2-BIB0093|cit93","unstructured":"Clinical efficacy and safty of prophylactic hyperthermic intraperitoneal chemotherapy for locally advanced gastric cancer after curative surgery: a prospective, randomized, open-label clinical study https:\/\/www.chictr.org.cn\/showproj.html?proj=59692 (first recieved 18 September 2020)"},{"issue":"3","key":"10.1002\/14651858.CD015698.pub2-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/(SICI)1097-0142(19990201)85:3<529::AID-CNCR3>3.0.CO;2-9","article-title":"Successful intraperitoneal hyperthermic chemoperfusion for the prevention of postoperative peritoneal recurrence in patients with advanced gastric carcinoma","volume":"85","author":"Fujimoto","year":"1999","journal-title":"Cancer"},{"key":"10.1002\/14651858.CD015698.pub2-BIB0095|cit95","doi-asserted-by":"publisher","first-page":"670651","DOI":"10.3389\/fonc.2021.670651","article-title":"Intraperitoneal chemotherapy using fluorouracil implants combined with radical resection and postoperative adjuvant chemotherapy for stage III gastric cancer: a multi-center, randomized, open-label, controlled clinical study","volume":"11","author":"Xu","year":"2021","journal-title":"Frontiers in Oncology"},{"key":"10.1002\/14651858.CD015698.pub2-BIB0096|cit96","unstructured":"Fluorouracil implants used for intraperitoneal chemotherapy during operation for treatment of phase III gastric cancer https:\/\/clinicaltrials.gov\/study\/NCT02269904"},{"issue":"6","key":"10.1002\/14651858.CD015698.pub2-BIB0097|cit97","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1245\/s10434-011-1631-5","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer: final results of a phase III randomized clinical trial","volume":"18","author":"Yang","year":"2011","journal-title":"Annals of Surgical Oncology"},{"key":"10.1002\/14651858.CD015698.pub2-BIB0098|cit98","unstructured":"Surgery plus intraoperative peritoneal hyperthermic chemotherapy (IPHC) to treat peritoneal carcinomatosis (IPHC) https:\/\/clinicaltrials.gov\/study\/NCT00454519 (first received 30 March 2007)"},{"issue":"22","key":"10.1002\/14651858.CD015698.pub2-BIB0099|cit99","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.3969\/j.issn.1000-8179.2012.22.012","article-title":"Cytoreductive surgery plus hyperthermic intra-peritoneal chemotherapy for peritoneal carcinomatosis from gastric cancer","volume":"39","author":"Li","year":"2012","journal-title":"Chinese Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD015698.pub2-BIB0100|cit100","doi-asserted-by":"crossref","unstructured":"Li Y Yang X Yang G Zhou Y Yonrmura Y An evaluation of cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy on patients with peritoneal carcinomatosis: Final results of a phase II prospective and randomized clinical trial Journal of Clinical Oncology 2011","DOI":"10.1200\/jco.2011.29.15_suppl.4051"},{"issue":"5","key":"10.1002\/14651858.CD015698.pub2-BIB0101|cit101","doi-asserted-by":"publisher","first-page":"448","DOI":"10.3760\/cma.j.issn.1671-0274.2008.05.011","article-title":"Efficacy of early continuous hyperthermic peritoneal perfusion on patients with advanced gastric carcinoma after surgical resection","volume":"11","author":"Yin","year":"2008","journal-title":"Zhonghua Wei Chang Wai Ke za Zhi [Chinese Journal of Gastrointestinal Surgery]"},{"issue":"4","key":"10.1002\/14651858.CD015698.pub2-BIB0102|cit102","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3969\/j.issn.1000-8179.2010.04.015","article-title":"Efficacy of intraoperative hyperthermic peritoneal perfusion on 60 patients with advanced gastric carcinoma","volume":"37","author":"Zhan","year":"2010","journal-title":"Chinese Journal of Clinical Oncology"},{"issue":"22","key":"10.1002\/14651858.CD015698.pub2-BIB0103|cit103","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.3969\/j.issn.1000-8179.2012.22.011","article-title":"Prognostic analysis of patients with advanced gastric cancer undergoing intraoperative chemohyperthermic peritoneal perfusion","volume":"39","author":"Zhan","year":"2012","journal-title":"Chinese Journal of Clinical Oncology"},{"issue":"10","key":"10.1002\/14651858.CD015698.pub2-BIB0104|cit104","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.2217\/fon-2021-1414","article-title":"A phase III trial of neoadjuvant intraperitoneal and systemic chemotherapy for gastric cancer with peritoneal metastasis","volume":"18","author":"Lu","year":"2022","journal-title":"Future Oncology (London, England)"},{"key":"10.1002\/14651858.CD015698.pub2-BIB0105|cit105","doi-asserted-by":"crossref","unstructured":"Yan C Yang Z Shi Z Lu S Shi M Nie M Intraperitoneal and intravenous paclitaxel plus S-1 versus intravenous paclitaxel plus S-1 in gastric cancer patients with peritoneal metastasis: Results from the multicenter, randomized, phase 3 DRAGON-01 trial Journal of Clinical Oncology 2025 10.1200\/JCO.2025.43.4_suppl.327","DOI":"10.1001\/jamaoncol.2026.1347"},{"key":"10.1002\/14651858.CD015698.pub2-BIB0106|cit106","unstructured":"The multicenter randomized cotrolled trial on neoadjuvant intraperitoneal & systemic chemotherapy (NIPS) for gastric cancer with peritoneal metastasis https:\/\/www.chictr.org.cn\/showproj.html?proj=15613 (first received 09 November 2016)"},{"key":"10.1002\/14651858.CD015698.pub2-BIB0107|cit107","unstructured":"A Bidirectional Conversion Treatment for Gastric Cancer with Peritoneal Metastasis: a Prospective Phase II Clinical Research https:\/\/www.chictr.org.cn\/showproj.html?proj=20551 (first received 08 August 2017)"},{"issue":"1","key":"10.1002\/14651858.CD015698.pub2-BIB0108|cit108","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1186\/s12885-020-6701-2","article-title":"Study protocol of a multicenter phase III randomized controlled trial investigating the efficiency of the combination of neoadjuvant chemotherapy (NAC) and neoadjuvant laparoscopic intraperitoneal hyperthermic chemotherapy (NLHIPEC) followed by R0 gastrectomy with intraoperative HIPEC for advanced gastric cancer (AGC): dragon II trial","volume":"20","author":"Beeharry","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1002\/14651858.CD015698.pub2-BIB0109|cit109","unstructured":"Combined neoadjuvant chemotherapy (NAC) and laparoscopic intraperitoneal hyperthermic chemotherapy (L-HIPEC) followed by R0 gastrectomy for locally advanced gastric cancer with serosal invasion (cT4-LAGC): A multicentric randomized controlled trial https:\/\/www.chictr.org.cn\/showproj.html?proj=40134 (first received 16 July 2019)"},{"key":"10.1002\/14651858.CD015698.pub2-BIB0110|cit110","unstructured":"Intraperitoneal chemotherapy and systemic chemotherapy versus systemic chemotherapy after curative resection of serosa-positive gastric cancer (EPIC-GC) https:\/\/clinicaltrials.gov\/study\/NCT02205008 (first received 31 July 2014)"},{"key":"10.1002\/14651858.CD015698.pub2-BIB0111|cit111","unstructured":"Efficacy of HIPEC in the treatment of patients with locally advanced gastric cancer (HIPEC) https:\/\/clinicaltrials.gov\/study\/NCT02240524 (first received 15 September 2014)"},{"key":"10.1002\/14651858.CD015698.pub2-BIB0112|cit112","unstructured":"Efficacy of HIPEC in the treatment of locally advanced gastric cancer after radical gastrectomy with D2 (EHTLAGCRGD2) https:\/\/clinicaltrials.gov\/study\/NCT02356276 (first received 5 February 2015)"},{"key":"10.1002\/14651858.CD015698.pub2-BIB0113|cit113","doi-asserted-by":"publisher","first-page":"15_suppl","DOI":"10.1200\/JCO.2020.38.15suppl.4538","article-title":"PILGRIM: phase III clinical trial in evaluating the role of hyperthermic intraperitoneal chemotherapy for locally advanced gastric cancer patients after radical gastrectomy with D2 lymphadenectomy(HIPEC-01)","volume":"38","author":"Liang","year":"2020","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD015698.pub2-BIB0114|cit114","unstructured":"Radical gastrectomy and hyperthermic intraperitoneal chemotherapy (HIPEC) in locally advanced gastric cancer https:\/\/clinicaltrials.gov\/study\/NCT02528110 (first received 19 August 2015)"},{"key":"10.1002\/14651858.CD015698.pub2-BIB0115|cit115","unstructured":"Perioperative chemotherapy combined with HIPEC for high-risk advanced gastric cancer (HIPEC) https:\/\/clinicaltrials.gov\/study\/NCT02960061 (first received 9 November 2016)"},{"key":"10.1002\/14651858.CD015698.pub2-BIB0116|cit116","unstructured":"Efficacy of HIPEC combined with systemic chemotherapy and CRS on peritoneal metastases from gastric cancer https:\/\/clinicaltrials.gov\/study\/NCT03179579 (first received 7 June 2017)"},{"key":"10.1002\/14651858.CD015698.pub2-BIB0117|cit117","unstructured":"Comparison of the efficiency between intraoperative and postoperative hyperthermic intraperitoneal chemotherapy with docetaxel combine oxaliplatin in patients with advanced gastric cancer https:\/\/clinicaltrials.gov\/study\/NCT04522011 (first received 21 August 2020)"},{"issue":"23","key":"10.1002\/14651858.CD015698.pub2-BIB0118|cit118","doi-asserted-by":"publisher","first-page":"5666","DOI":"10.3390\/jcm10235666","article-title":"Intraperitoneal chemotherapy as adjuvant or perioperative chemotherapy for patients with type 4 scirrhous gastric cancer: PHOENIX-GC2 trial","volume":"10","author":"Ishigami","year":"2021","journal-title":"Journal of Clinical Medicine"},{"key":"10.1002\/14651858.CD015698.pub2-BIB0119|cit119","doi-asserted-by":"crossref","unstructured":"Ishigami H Omori T Tsuji Y Shinohara H Yabusaki H Kobayashi D Combined intraperitoneal and systemic chemotherapy as adjuvant or perioperative chemotherapy for patients with type 4 scirrhous gastric cancer: PHOENIX-GC2 trial Journal of Clinical Oncology 2023 10.1200\/jco.2023.41.4suppl.tps477","DOI":"10.1200\/JCO.2023.41.4_suppl.TPS477"},{"key":"10.1002\/14651858.CD015698.pub2-BIB0120|cit120","unstructured":"Randomized phase III trial comparing combined systemic and intraperitoneal chemotherapy versus systemic chemotherapy as adjuvant or perioperative chemotherapy in patients with type 4 advanced gastric cancer (PHOENIX-GC2 trial) https:\/\/jrct.niph.go.jp\/en-latest-detail\/jRCT2031200087 (first received 17 Aug 2020)"},{"key":"10.1002\/14651858.CD015698.pub2-BIB0121|cit121","unstructured":"Hyperthermic intraperitoneal chemotherapy (HIPEC) in locally advanced gastric cancer https:\/\/clinicaltrials.gov\/study\/NCT04345770 (first received 14 April 2020)"},{"issue":"1","key":"10.1002\/14651858.CD015698.pub2-BIB0122|cit122","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1186\/s12885-021-08872-8","article-title":"Preventive HIPEC in combination with perioperative FLOT versus FLOT alone for resectable diffuse type gastric and gastroesophageal junction type II\/III adenocarcinoma - the phase III \"PREVENT\"- (FLOT9) trial of the AIO \/CAOGI \/ACO","volume":"21","author":"G\u00f6tze","year":"2021","journal-title":"BMC Cancer"},{"issue":"3_suppl","key":"10.1002\/14651858.CD015698.pub2-BIB0123|cit123","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1200\/JCO.2024.42.3_suppl.359","article-title":"Safety of preventive HIPEC in combination with perioperative FLOT versus FLOT alone for resectable diffuse type gastric and gastroesophageal junction type II\/III adenocarcinoma: An interim safety analysis from the phase III PREVENT trial of the AIO\/CAOGI\/ACO","volume":"42","author":"Goetze","year":"2024","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD015698.pub2-BIB0124|cit124","unstructured":"HIPEC + FLOT vs. FLOT alone in patients with gastric cancer and GEJ (PREVENT) (PREVENT) https:\/\/clinicaltrials.gov\/study\/NCT04447352 (first recieved 25 June 2020)"},{"key":"10.1002\/14651858.CD015698.pub2-BIB0125|cit125","doi-asserted-by":"publisher","first-page":"S1075","DOI":"10.1016\/j.annonc.2021.08.1549","article-title":"1440TiP Preventive HIPEC in combination with perioperative FLOT versus FLOT alone for resectable diffuse type gastric and gastroesophageal junction type II\/III adenocarcinoma: The phase III \"PREVENT\" trial of the AIO\/CAOGI\/ACO","volume":"32","author":"Bankstahl","year":"2021","journal-title":"Annals of Oncology"},{"key":"10.1002\/14651858.CD015698.pub2-BIB0126|cit126","unstructured":"Prophylactic preoperative HIPEC in advanced gastric cancer at high risk of peritoneal recurrence (CHIMERA) https:\/\/clinicaltrials.gov\/study\/NCT04597294 (first received at 22 October 2020)"},{"key":"10.1002\/14651858.CD015698.pub2-BIB0127|cit127","unstructured":"Preoperative intraperitoneal chemotherapy in adjuvant hyperthermiaadjunctive therapy in advanced gastric cancer with high-risk of peritoneal recurrence - a multicentre randomized trial https:\/\/www.clinicaltrialsregister.eu\/ctr-search\/trial\/2020-001419-25\/PL (first received 05 January 2021)"},{"key":"10.1002\/14651858.CD015698.pub2-BIB0128|cit128","unstructured":"Comparative study of lobaplatin and paclitaxel in advanced gastric cancer patients with D2 surgery combined with hyperthermic intraperitoneal chemotherapy (WUHIPEC01) https:\/\/clinicaltrials.gov\/study\/NCT04808466 (first received 22 March 2021)"},{"issue":"3","key":"10.1002\/14651858.CD015698.pub2-BIB0129|cit129","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1515\/pp-2022-0111","article-title":"Pressurized intraperitoneal aerosol chemotherapy (PIPAC) in multimodal therapy for patients with oligometastatic peritoneal gastric cancer: a randomized multicenter phase III trial PIPAC VEROne","volume":"7","author":"Casella","year":"2022","journal-title":"Pleura and Peritoneum"},{"key":"10.1002\/14651858.CD015698.pub2-BIB0130|cit130","unstructured":"Casella F Bencivenga M Meloni F Puccio C Rigoli R Zacchi I Preliminary data from randomized multicenter phase III trial PIPAC VEROne Pleura and Peritoneum 2024 10.1515\/pp-2024-0031"},{"key":"10.1002\/14651858.CD015698.pub2-BIB0131|cit131","unstructured":"PIPAC in multimodal therapy for patients with oligometastatic peritoneal gastric cancer https:\/\/clinicaltrials.gov\/study\/NCT05303714 (first received 31 March 2022)"},{"key":"10.1002\/14651858.CD015698.pub2-BIB0132|cit132","unstructured":"Pressurized intraperitoneal aerosol chemotherapy (PIPAC) in multimodal therapy for patients with oligometastatic peritoneal gastric cancer: a randomized multicenter phase III trial. PIPAC_VEROne https:\/\/www.clinicaltrialsregister.eu\/ctr-search\/trial\/2021-000830-33\/IT (first received 30 August 2021)"},{"key":"10.1002\/14651858.CD015698.pub2-BIB0133|cit133","unstructured":"Effect of HIPEC After Radical Surgery on Long-term Survival for Locally Advanced Gastric Cancer https:\/\/clinicaltrials.gov\/study\/NCT06525714 (first received 29 July 2024)"},{"key":"10.1002\/14651858.CD015698.pub2-BIB0134|cit134","unstructured":"Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity (STOPGAP II) https:\/\/clinicaltrials.gov\/study\/NCT07001748 (first received 3 June 2025)"},{"issue":"10","key":"10.1002\/14651858.CD015698.pub2-BIB0135|cit135","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1093\/bjs\/znab192","article-title":"Core outcome set for surgical trials in gastric cancer (GASTROS study): international patient and healthcare professional consensus","volume":"108","author":"Alkhaffaf","year":"2021","journal-title":"British Journal of Surgery"},{"issue":"6","key":"10.1002\/14651858.CD015698.pub2-BIB0136|cit136","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1002\/wjs.12186","article-title":"Cytoreductive surgery plus hyperthermic intraoperative peritoneal chemotherapy for people with peritoneal metastases from colorectal, ovarian or gastric origin: a systematic review of randomized controlled trials","volume":"48","author":"Gurusamy","year":"2024","journal-title":"World Journal of Surgery"},{"issue":"7","key":"10.1002\/14651858.CD015698.pub2-BIB0137|cit137","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1016\/j.gassur.2024.04.007","article-title":"Prophylaxis and treatment of peritoneal carcinomatosis of gastric origin using hyperthermic intraperitoneal chemotherapy: a systematic review and meta-analysis of randomized trials","volume":"27","author":"Stefano","year":"2024","journal-title":"Journal of Gastrointestinal Surgery"},{"issue":"10","key":"10.1002\/14651858.CD015698.pub2-BIB0138|cit138","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.3390\/cancers16101929","article-title":"Efficacy of cytoreductive surgery (CRS) + HIPEC in gastric cancer with peritoneal metastasis: systematic review and meta-analysis","volume":"16","author":"Langellotti","year":"2024","journal-title":"Cancers"},{"key":"10.1002\/14651858.CD015698.pub2-BIB0139|cit139","doi-asserted-by":"publisher","first-page":"1503045","DOI":"10.3389\/fonc.2024.1503045","article-title":"Efficacy analysis of prophylactic hyperthermic intraperitoneal chemotherapy in patients with locally advanced gastric cancer: a retrospective study","volume":"14","author":"Gong","year":"2025","journal-title":"Frontiers in Oncology"},{"issue":"11","key":"10.1002\/14651858.CD015698.pub2-BIB0140|cit140","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1007\/s11605-023-05823-5","article-title":"Prognostic analysis of prophylactic hyperthermic intraperitoneal chemotherapy for advanced gastric cancer: a propensity score-matched analysis","volume":"27","author":"Liu","year":"2023","journal-title":"Journal of Gastrointestinal Surgery"},{"issue":"1","key":"10.1002\/14651858.CD015698.pub2-BIB0141|cit141","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1186\/s12957-024-03526-y","article-title":"Efficacy of neoadjuvant chemotherapy combined with prophylactic intraperitoneal hyperthermic chemotherapy for patients diagnosed with clinical T4 gastric cancer who underwent laparoscopic radical gastrectomy: a retrospective cohort study based on propensity score matching","volume":"22","author":"Lv","year":"2024","journal-title":"World Journal of Surgical Oncology"},{"issue":"13","key":"10.1002\/14651858.CD015698.pub2-BIB0142|cit142","doi-asserted-by":"publisher","first-page":"8551","DOI":"10.1245\/s10434-022-12348-9","article-title":"Comparative study of the efficacy and safety of radical surgery with or without hyperthermic intraperitoneal chemotherapy in locally advanced gastric cancer: a propensity score-matching analysis","volume":"29","author":"Shen","year":"2022","journal-title":"Annals of Surgical Oncology"},{"issue":"1","key":"10.1002\/14651858.CD015698.pub2-BIB0143|cit143","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1245\/s10434-024-16328-z","article-title":"Insight into predictors of cytoreduction score following cytoreductive surgery-hyperthermic intraperitoneal chemotherapy for gastric peritoneal carcinomatosis improves patient selection and prognostic outcomes","volume":"32","author":"Hamed","year":"2025","journal-title":"Annals of Surgical Oncology"},{"issue":"8","key":"10.1002\/14651858.CD015698.pub2-BIB0144|cit144","doi-asserted-by":"crossref","first-page":"110000","DOI":"10.1016\/j.ejso.2025.110000","article-title":"Survival outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in selected patients with stage IV gastric adenocarcinoma - A Canadian case series","volume":"51","author":"B\u00e9nard","year":"2025","journal-title":"European Society of Surgical Oncology"},{"issue":"11","key":"10.1002\/14651858.CD015698.pub2-BIB0145|cit145","doi-asserted-by":"publisher","first-page":"3774","DOI":"10.3390\/jcm12113774","article-title":"Treatment of peritoneal surface malignancies by cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in Spain: results of the National Registry of the Spanish Group of Peritoneal Oncologic Surgery (REGECOP)","volume":"12","author":"Manzanedo","year":"2023","journal-title":"Journal of Clinical Medicine"},{"issue":"13","key":"10.1002\/14651858.CD015698.pub2-BIB0146|cit146","doi-asserted-by":"publisher","first-page":"8549","DOI":"10.1245\/s10434-024-16142-7","article-title":"Survival outcomes of cytoreductive surgery with HIPEC in gastric adenocarcinoma: a national cancer database study","volume":"31","author":"Khomiak","year":"2024","journal-title":"Annals of Surgical Oncology"},{"issue":"23","key":"10.1002\/14651858.CD015698.pub2-BIB0147|cit147","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1200\/JCO.18.01688","article-title":"Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer With Peritoneal Metastases (CYTO-CHIP study): A Propensity Score Analysis","volume":"37","author":"Bonnot","year":"2019","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD015698.pub2-BIB0148|cit148","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1741-7015-8-18","article-title":"CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials","volume":"8","author":"CONSORT Group","year":"2010","journal-title":"BMC Medicine"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T08:21:04Z","timestamp":1782116464000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD015698.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Central Editorial Service","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,10,9]]},"references-count":148,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd015698.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,9]]}}}